tiprankstipranks
Mirum Pharmaceuticals (MIRM)
NASDAQ:MIRM
US Market
MIRM
Mirum Pharmaceuticals
RESEARCH TOOLSreports
Want to see MIRM full AI Analyst Report?

Mirum Pharmaceuticals (MIRM) Ratios

749 Followers

Mirum Pharmaceuticals Ratios

MIRM's free cash flow for Q4 2025 was $0.81. For the 2025 fiscal year, MIRM's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.67 2.67 3.10 4.45 2.94
Quick Ratio
 2.55 2.55 2.93 4.19 2.85
Cash Ratio
 1.44 1.44 1.76 3.29 0.43
Solvency Ratio
 <0.01 <0.01 -0.14 -0.38 -0.63
Operating Cash Flow Ratio
 0.27 0.27 0.08 -0.81 -1.86
Short-Term Operating Cash Flow Coverage
 26.10 26.10 0.00 0.00 0.00
Net Current Asset Value
$ 21.56M$ 21.56M$ -52.33M$ -10.41M$ -20.64M
Leverage Ratios
Debt-to-Assets Ratio
 0.38 0.38 0.47 0.48 <0.01
Debt-to-Equity Ratio
 1.02 1.02 1.41 1.24 0.02
Debt-to-Capital Ratio
 0.50 0.50 0.58 0.55 0.02
Long-Term Debt-to-Capital Ratio
 0.50 0.50 0.58 0.55 0.00
Financial Leverage Ratio
 2.68 2.68 2.97 2.60 2.48
Debt Service Coverage Ratio
 0.73 0.92 -3.49 -9.10 -7.29
Interest Coverage Ratio
 -1.54 -1.54 -6.12 -7.23 -8.21
Debt to Market Cap
 0.07 0.08 0.16 0.25 0.00
Interest Debt Per Share
 6.65 6.65 6.99 7.91 0.54
Net Debt to EBITDA
 1.63 1.32 -1.95 -0.16 0.21
Profitability Margins
Gross Profit Margin
80.76%80.71%75.77%74.76%83.94%
EBIT Margin
-1.97%-1.35%-21.55%-79.04%-163.62%
EBITDA Margin
2.68%3.30%-14.54%-73.23%-159.42%
Operating Profit Margin
-4.25%-4.25%-26.00%-58.57%-170.28%
Pretax Profit Margin
-4.11%-4.11%-25.80%-87.15%-184.36%
Net Profit Margin
-4.48%-4.48%-26.10%-87.68%-176.05%
Continuous Operations Profit Margin
-4.48%-4.48%-26.10%-87.68%-176.05%
Net Income Per EBT
109.04%109.04%101.19%100.61%95.49%
EBT Per EBIT
96.80%96.80%99.21%148.80%108.27%
Return on Assets (ROA)
-2.77%-2.77%-13.11%-25.27%-38.44%
Return on Equity (ROE)
-8.53%-7.42%-38.97%-65.72%-95.51%
Return on Capital Employed (ROCE)
-3.47%-3.47%-16.10%-19.51%-45.53%
Return on Invested Capital (ROIC)
-3.46%-3.46%-16.05%-19.47%-43.34%
Return on Tangible Assets
-4.02%-4.02%-20.89%-41.51%-46.15%
Earnings Yield
-0.50%-0.59%-4.48%-13.54%-20.56%
Efficiency Ratios
Receivables Turnover
 4.23 4.23 4.30 2.74 3.21
Payables Turnover
 10.43 10.46 5.59 6.34 1.42
Inventory Turnover
 4.03 4.04 3.64 2.11 2.22
Fixed Asset Turnover
 0.00 0.00 34.33 93.66 32.86
Asset Turnover
 0.62 0.62 0.50 0.29 0.22
Working Capital Turnover Ratio
 1.46 1.71 1.19 0.88 0.62
Cash Conversion Cycle
 141.92 141.77 119.62 248.70 21.47
Days of Sales Outstanding
 86.35 86.35 84.82 133.11 113.65
Days of Inventory Outstanding
 90.55 90.31 100.16 173.13 164.15
Days of Payables Outstanding
 34.98 34.89 65.35 57.54 256.33
Operating Cycle
 176.90 176.66 184.98 306.24 277.80
Cash Flow Ratios
Operating Cash Flow Per Share
 1.11 1.11 0.22 -1.74 -3.55
Free Cash Flow Per Share
 1.09 1.09 0.20 -2.23 -3.56
CapEx Per Share
 0.02 0.02 0.02 0.49 <0.01
Free Cash Flow to Operating Cash Flow
 0.98 0.98 0.90 1.28 1.00
Dividend Paid and CapEx Coverage Ratio
 58.52 58.52 10.40 -3.53 -432.14
Capital Expenditure Coverage Ratio
 58.52 58.52 10.40 -3.53 -432.14
Operating Cash Flow Coverage Ratio
 0.17 0.17 0.03 -0.23 -54.91
Operating Cash Flow to Sales Ratio
 0.11 0.11 0.03 -0.38 -1.56
Free Cash Flow Yield
1.16%1.38%0.47%-7.54%-18.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -196.58 -169.72 -22.35 -7.39 -4.86
Price-to-Sales (P/S) Ratio
 8.81 7.61 5.83 6.48 8.56
Price-to-Book (P/B) Ratio
 14.59 12.60 8.71 4.85 4.65
Price-to-Free Cash Flow (P/FCF) Ratio
 83.70 72.26 210.57 -13.26 -5.48
Price-to-Operating Cash Flow Ratio
 82.27 71.03 190.32 -17.01 -5.49
Price-to-Earnings Growth (PEG) Ratio
 -1.21 2.28 0.42 29.62 -0.11
Price-to-Fair Value
 14.59 12.60 8.71 4.85 4.65
Enterprise Value Multiple
 330.74 231.78 -42.07 -9.00 -5.16
Enterprise Value
 4.74B 3.99B 2.06B 1.23B 634.05M
EV to EBITDA
 339.77 231.78 -42.07 -9.00 -5.16
EV to Sales
 9.10 7.65 6.12 6.59 8.23
EV to Free Cash Flow
 86.41 72.68 220.78 -13.49 -5.27
EV to Operating Cash Flow
 84.93 71.43 199.55 -17.32 -5.28
Tangible Book Value Per Share
 1.07 1.07 -0.51 -0.10 2.46
Shareholders’ Equity Per Share
 6.27 6.27 4.75 6.08 4.20
Tax and Other Ratios
Effective Tax Rate
 -0.09 -0.09 -0.01 >-0.01 0.05
Revenue Per Share
 10.39 10.39 7.09 4.56 2.28
Net Income Per Share
 -0.47 -0.47 -1.85 -4.00 -4.01
Tax Burden
 1.09 1.09 1.01 1.01 0.95
Interest Burden
 2.08 3.04 1.20 1.10 1.13
Research & Development to Revenue
 0.36 0.36 0.42 0.55 1.39
SG&A to Revenue
 0.49 0.49 0.60 0.75 0.00
Stock-Based Compensation to Revenue
 0.14 0.14 0.14 0.19 0.35
Income Quality
 -2.39 -2.39 -0.12 0.43 0.89
Currency in USD